VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 624 filers reported holding VANECK VECTORS ETF TR in Q2 2020. The put-call ratio across all filers is 0.68 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,195 | -10.6% | 44,389 | 0.0% | 0.25% | -11.2% |
Q2 2023 | $1,337 | -7.0% | 44,389 | -0.2% | 0.28% | -13.1% |
Q1 2023 | $1,438 | +11.6% | 44,457 | -1.1% | 0.32% | +15.5% |
Q4 2022 | $1,289 | -99.9% | 44,970 | +0.9% | 0.28% | -0.4% |
Q3 2022 | $1,075,000 | -14.3% | 44,559 | -2.7% | 0.28% | -9.2% |
Q2 2022 | $1,254,000 | -29.6% | 45,794 | -1.5% | 0.31% | -20.3% |
Q1 2022 | $1,782,000 | +19.5% | 46,479 | -0.2% | 0.38% | +20.4% |
Q4 2021 | $1,491,000 | +8.7% | 46,564 | 0.0% | 0.32% | +0.6% |
Q3 2021 | $1,372,000 | -29.0% | 46,564 | -5.7% | 0.32% | -45.1% |
Q2 2021 | $1,933,000 | +22.8% | 49,364 | +1.9% | 0.58% | +58.5% |
Q1 2021 | $1,574,000 | -11.9% | 48,444 | -2.3% | 0.36% | -18.0% |
Q4 2020 | $1,786,000 | -7.6% | 49,584 | +0.4% | 0.44% | -23.1% |
Q3 2020 | $1,933,000 | +5.9% | 49,364 | -0.9% | 0.58% | -0.2% |
Q2 2020 | $1,826,000 | +55.1% | 49,792 | -2.6% | 0.58% | +44.5% |
Q1 2020 | $1,177,000 | -4.4% | 51,100 | +21.5% | 0.40% | +13.3% |
Q4 2019 | $1,231,000 | +9.6% | 42,051 | 0.0% | 0.35% | +1.1% |
Q3 2019 | $1,123,000 | -0.3% | 42,051 | -4.6% | 0.35% | -2.2% |
Q2 2019 | $1,126,000 | +3.7% | 44,064 | -9.0% | 0.36% | -0.3% |
Q1 2019 | $1,086,000 | +1.5% | 48,439 | -4.5% | 0.36% | -7.5% |
Q4 2018 | $1,070,000 | +6.5% | 50,719 | -6.6% | 0.39% | +23.2% |
Q3 2018 | $1,005,000 | -20.9% | 54,288 | -4.6% | 0.31% | -24.7% |
Q2 2018 | $1,270,000 | +1.8% | 56,913 | +0.2% | 0.42% | +7.8% |
Q1 2018 | $1,248,000 | -7.2% | 56,785 | -1.9% | 0.39% | -13.6% |
Q4 2017 | $1,345,000 | +8.9% | 57,856 | +7.6% | 0.45% | +3.9% |
Q3 2017 | $1,235,000 | -6.5% | 53,788 | -10.1% | 0.43% | -11.7% |
Q2 2017 | $1,321,000 | +8.1% | 59,843 | +11.7% | 0.49% | -0.2% |
Q1 2017 | $1,222,000 | -99.9% | 53,588 | +16.2% | 0.49% | +17.3% |
Q4 2016 | $964,948,000 | +122666.9% | 46,126 | +55.2% | 0.42% | +14.2% |
Q3 2016 | $786,000 | – | 29,729 | – | 0.36% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Memorial Sloan Kettering Cancer Center | 738,500 | $20,220,000 | 66.82% |
Baymount Management LP | 145,000 | $3,970,000 | 28.08% |
New Harbor Financial Group, LLC | 1,371,341 | $37,547,000 | 18.51% |
New Harbor Financial Group, LLC | 1,291,700 | $35,366,000 | 17.44% |
MKP Capital Management, L.L.C. | 1,500,000 | $41,070,000 | 13.74% |
Windmill Hill Asset Management Ltd | 844,600 | $23,125,000 | 11.94% |
Hollow Brook Wealth Management LLC | 768,567 | $21,043,000 | 11.57% |
Grand Central Investment Group | 261,915 | $7,171,000 | 10.33% |
Point72 Europe (London) LLP | 1,467,000 | $40,166,000 | 8.50% |
Slate Path Capital LP | 4,600,000 | $125,948,000 | 7.87% |